EFN

A new drug called Ellaone is currently being tested in Britain as the new morning-after pill. The drug Ellaone is considered to be twice as effective as the current morning-after drug called levonorgestrel. Currently, levonorgestrel gives women a three day period. The new drug Ellaone will give women 5 days and is twice as effective.

During the testing of Ellaone a group of 5500 women were put into two different groups. One group was given one dose of Ellaone (30 mg) and the other group received a 175 mg dose of Levonorgestrel within a 5 day period of unprotected relations. What they found from this study was that Ellaone delays the release of the egg for fertilization while Levonorgestrel destroys the implanted embryo. The results of the study were that in the Ellaone group there were 15 pregnancies and in the Levonorgestrel group there were 22. In conclusion they found that the Ellaone drug was 98% effective if taken five days after and the Levonorgestrel drug was only 95% effective.

There have been some concerns raised regarding the new drug. People are concerned that this will encourage women to have more casual relationships without consequence. They are also concerned with the time you can wait to use the drug and calling it a abortive agent and not a contraceptive. Overall, it has been doing well in Britain and seems to be a breakthrough for the drug world.